Abbvie Inc (NYSE:ABBV)
| 158.05 BATS BZX Real-Time Price As of 11:49am ET |  +0.05 / +0.03%Today’s Change | 134.09 Today|||52-Week Range 175.91 | -2.20% Year-to-Date |
Latest ABBV News | Press Releases
Today’s Trading
| Previous close | 158.00 |
| Today’s open | 157.96 |
| Day’s range | 157.75 - 158.52 |
| Volume | 698,561 |
| Average volume (3 months) | 5,940,097 |
| Market cap | $278.8B |
Data as of 11:49am ET, 03/30/2023
Growth & Valuation
| Earnings growth (last year) | +2.68% |
| Earnings growth (this year) | -19.62% |
| Earnings growth (next 5 years) | +4.00% |
| Revenue growth (last year) | +3.30% |
| P/E ratio | 23.9 |
| Price/Sales | 4.95 |
| Price/Book | 16.20 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| NVONovo Nordisk | +0.98 | +0.63% |
| MRKMerck | +0.77 | +0.73% |
| LLYEli Lilly and Co | +2.47 | +0.74% |
| PFEPfizer | +0.05 | +0.12% |
Data as of 11:49am ET, 03/30/2023
Financials
| Next reporting date | April 27, 2023 |
| EPS forecast (this quarter) | $2.56 |
| Annual revenue (last year) | $58.1B |
| Annual profit (last year) | $11.8B |
| Net profit margin | 20.29% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters North Chicago, Illinois |
Forecasts
